drugset / Trial / NCT04617561
Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II
RandomizedParallel-groupOpen-labelTreatment
Summary
A randomized controlled open-label clinical trial of ursodeoxycholic acid combined with low dose glucocorticoid in the treatment of PBC With AIH Features II to asses efficacy and safety.
Timeline
- Start
- 2020-11-01
- Primary completion
- 2022-11-01
- Completion
- 2022-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylprednisolone | Other / unclassified | 2 mg | Oral |
| Subject | Methylprednisolone | Other / unclassified | 4 mg | Oral |
| Comparator | Ursodeoxycholic Acid | Small molecule | 13 mg/kg | Oral |
| Comparator | Ursodeoxycholic Acid | Small molecule | 15 mg/kg | Oral |